Related Experiment Video
Updated: Aug 14, 2025
10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.8K
Movement Disorders Associated With Radiotherapy and Surgical Procedures
Bharath Kumar Surisetti1, Shweta Prasad1,2, Vikram Venkappayya Holla1
1Department of Neurology, National Institute of Mental Health & Neurosciences, Bengaluru, Karnataka, India.
Journal of Movement Disorders
|January 11, 2023
Summary
Interventional procedures like radiotherapy and surgery can cause disabling movement disorders. Early diagnosis and awareness are crucial for effective treatment of these rare but severe conditions.
Area of Science:
- Neurology
- Interventional Medicine
Background:
- Movement disorders are infrequent but potentially disabling complications following interventional procedures.
- These sequelae often present with variable symptoms and delayed onset, sometimes exceeding the severity of the initial condition.
Purpose of the Study:
- To review the phenomenology, pathophysiology, and treatment of movement disorders secondary to interventional procedures.
- To increase awareness and improve diagnostic accuracy for these iatrogenic conditions.
Main Methods:
- This is a narrative review synthesizing existing literature.
- The review covers movement disorders following radiotherapy, dental procedures, and various surgeries.
Main Results:
- Movement disorders post-intervention are diverse, often misdiagnosed, and can be severely debilitating.
- Delayed diagnosis is common due to limited awareness.
Conclusions:
- Increased recognition of procedure-induced movement disorders is essential for timely diagnosis and management.
- Further research into pathophysiology and treatment is warranted.
More Related Videos
Related Concept Videos
01:24Parkinson's Disease: Treatment
333
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
333
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
293
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
293
01:31Skeletal Muscle Relaxants: Therapeutic Uses
540
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
540
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
496
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
496
01:20Gastrointestinal Motility Disorders
536
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
536
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
404
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
404